- Home
- SONN vs TRT Comparison
SONN vs TRT Comparison
Compare SONN & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- TRT
- Stock Information
- Founded
- SONN N/A
- TRT 1958
- Country
- SONN United States
- TRT United States
- Employees
- SONN N/A
- TRT N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- TRT Industrial Machinery/Components
- Sector
- SONN Health Care
- TRT Technology
- Exchange
- SONN Nasdaq
- TRT Nasdaq
- Market Cap
- SONN 21.4M
- TRT 22.7M
- IPO Year
- SONN N/A
- TRT N/A
- Fundamental
- Price
- SONN $4.46
- TRT $8.11
- Analyst Decision
- SONN Strong Buy
- TRT
- Analyst Count
- SONN 1
- TRT 0
- Target Price
- SONN $20.00
- TRT N/A
- AVG Volume (30 Days)
- SONN 1.1M
- TRT 24.3K
- Earning Date
- SONN 08-13-2025
- TRT 11-11-2025
- Dividend Yield
- SONN N/A
- TRT N/A
- EPS Growth
- SONN N/A
- TRT N/A
- EPS
- SONN N/A
- TRT N/A
- Revenue
- SONN $1,000,000.00
- TRT $36,473,000.00
- Revenue This Year
- SONN $5,376.22
- TRT N/A
- Revenue Next Year
- SONN N/A
- TRT N/A
- P/E Ratio
- SONN N/A
- TRT N/A
- Revenue Growth
- SONN 1689.52
- TRT N/A
- 52 Week Low
- SONN $1.08
- TRT $4.62
- 52 Week High
- SONN $19.30
- TRT $7.88
- Technical
- Relative Strength Index (RSI)
- SONN 44.44
- TRT 85.13
- Support Level
- SONN $4.25
- TRT $5.61
- Resistance Level
- SONN $6.15
- TRT $6.20
- Average True Range (ATR)
- SONN 0.64
- TRT 0.35
- MACD
- SONN -0.21
- TRT 0.23
- Stochastic Oscillator
- SONN 9.90
- TRT 96.46
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About TRT Trio-Tech International
Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.